Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy

Advanced Drug Delivery Reviews

Volumn 61, Issue 2, 2009, Pages 128-139

  Griesenbach, Uta ^a   Alton, Eric W F W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Barriers to gene transfer; Clinical trials; Cystic fibrosis; Gene transfer; Non viral vectors; Viral vectors

Indexed keywords

BARRIERS TO GENE TRANSFER; CLINICAL TRIALS; CYSTIC FIBROSIS; NON-VIRAL VECTORS; VIRAL VECTORS;

BIOLOGICAL ORGANS; GENETIC ENGINEERING; INTERNET; TARGETS; VECTORS;

GENE TRANSFER;

ADENOVIRUS VECTOR; DEOXYRIBONUCLEASE; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; PLACEBO; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CLINICAL TRIAL; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE THERAPY; GENE TRANSFER; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; RNA SPLICING; STEM CELL TRANSPLANTATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CLINICAL TRIALS AS TOPIC; CYSTIC FIBROSIS; EXPECTORANTS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MUCUS; RESPIRATORY MUCOSA;

EID: 60149095412     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2008.09.010     Document Type: Review

References (132)

1. Breeze R.G., and Wheeldon E.B. The cells of the pulmonary airways. Am. Rev. Respir. Dis. 116 (1977) 705-777
2. Welsh M., Ramsey B.W., Accurso F., and Cutting G.R. Cystic fibrosis. In: Scriver A.B., Sly W.S., and Valle D. (Eds). The Molecular and Metabolic Basis of Inherited Disease (2001), McGraw-Hill, New York 5121-5188
3. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., and Chou J.L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
4. Alton E.W., Middleton P.G., Caplen N.J., Smith S.N., Steel D.M., Munkonge F.M., Jeffery P.K., Geddes D.M., Hart S.L., and Williamson R. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat. Genet. 5 (1993) 135-142
5. Drumm M.L., Pope H.A., Cliff W.H., Rommens J.M., Marvin S.A., Tsui L.C., Collins F.S., Frizzell R.A., and Wilson J.M. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 62 (1990) 1227-1233
6. Engelhardt J.F., Zepeda M., Cohn J.A., Yankaskas J.R., and Wilson J.M. Expression of the cystic fibrosis gene in adult human lung. J. Clin. Invest. 93 (1994) 737-749
7. Ferrari S., Griesenbach U., Geddes D.M., and Alton E. Immunological hurdles to lung gene therapy. Clin. Exp. Immunol. 132 (2003) 1-8
8. Ferrari S., Kitson C., Farley R., Steel R., Marriott C., Parkins D.A., Scarpa M., Wainwright B., Evans M.J., Colledge W.H., Geddes D.M., and Alton E.W. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Ther. 8 (2001) 1380-1386
9. McLachlan G., Davidson H., Fox E., Gill D.R., Hyde S.C., Griesenbach U., Alton E.W., Boyd A.C., Porteous D.J., and Collie D.D. Ovine lung comparision of non-viral gene transfer agents for CF gene therapy. Ped. Pulm. S28 (2005) 278-
10. Kushwah R., Oliver J.R., Cao H., and Hu J. Nacystelyn enhances adenoviral vector-mediated gene delivery to mouse airways. Gene Ther. 14 (2007) 1243-1248
11. Sanders N.N., Van R.E., De Smedt S.C., and Demeester J. Structural alterations of gene complexes by cystic fibrosis sputum. Am. J. Respir. Crit. Care Med. 164 (2001) 486-493
12. Perricone M.A., Rees D.D., Sacks C.R., Smith K.A., Kaplan J.M., and St George J.A. Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells. Hum. Gene Ther. 11 (2000) 1997-2008
13. Ziady A.G., Kelley T.J., Milliken E., Ferkol T., and Davis P.B. Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol. Ther. 5 (2002) 413-419
14. Pickles R.J., Fahrner J.A., Petrella J.M., Boucher R.C., and Bergelson J.M. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J. Virol. 74 (2000) 6050-6057
15. Sinn P.L., Shah A.J., Donovan M.D., and McCray Jr. P.B. Viscoelastic gel formulations enhance airway epithelial gene transfer with viral vectors. Am. J. Respir. Cell Mol. Biol. 32 (2005) 404-410
16. Worgall S., Leopold P.L., Wolff G., Ferris B., Van R.N., and Crystal R.G. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum. Gene Ther. 8 (1997) 1675-1684
17. Pickles R.J., Hirsh A.J., Gerard R.J., and Boucher R.C. Retargeting Ad5 fibers to bradykinin receptors expressed on the lumenal surface of human airway epithelium. Ped. Pulm. 22 (2001)
18. Cartier R., and Reszka R. Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems. Gene Ther. 9 (2002) 157-167
19. Klink D.T., Chao S., Glick M.C., and Scanlin T.F. Nuclear translocation of lactosylated poly-l-lysine/cDNA complex in cystic fibrosis airway epithelial cells. Mol. Ther. 3 (2001) 831-841
20. Katkin J.P., Gilbert B.E., Langston C., French K., and Beaudet A.L. Aerosol delivery of a beta-galactosidase adenoviral vector to the lungs of rodents. Hum. Gene Ther. 6 (1995) 985-995
21. Scaria A., St George J.A., Jiang C., Kaplan J.M., Wadsworth S.C., and Gregory R.J. Adenovirus-mediated persistent cystic fibrosis transmembrane conductance regulator expression in mouse airway epithelium. J. Virol. 72 (1998) 7302-7309
22. Harvey B.G., Leopold P.L., Hackett N.R., Grasso T.M., Williams P.M., Tucker A.L., Kaner R.J., Ferris B., Gonda I., Sweeney T.D., Ramalingam R., Kovesdi I., Shak S., and Crystal R.G. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin. Invest. 104 (1999) 1245-1255
23. Joseph P.M., O'Sullivan B.P., Lapey A., Dorkin H., Oren J., Balfour R., Perricone M.A., Rosenberg M., Wadsworth S.C., Smith A.E., St G.J., and Meeker D.P. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications. Hum. Gene Ther. 12 (2001) 1369-1382
24. Walters R.W., Grunst T., Bergelson J.M., Finberg R.W., Welsh M.J., and Zabner J. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J. Biol. Chem. 274 (1999) 10219-10226
25. Chirmule N., Raper S.E., Burkly L., Thomas D., Tazelaar J., Hughes J.V., and Wilson J.M. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions. J. Virol. 74 (2000) 3345-3352
26. Kolb M., Inman M., Margetts P.J., Galt T., and Gauldie J. Budesonide enhances repeated gene transfer and expression in the lung with adenoviral vectors. Am. J. Respir. Crit. Care Med. 164 (2001) 866-872
27. Croyle M.A., Chirmule N., Zhang Y., and Wilson J.M. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J. Virol. 75 (2001) 4792-4801
28. Toietta G., Koehler D.R., Finegold M.J., Lee B., Hu J., and Beaudet A.L. Reduced inflammation and improved airway expression using helper-dependent adenoviral vectors with a K18 promoter. Mol. Ther. 7 (2003) 649-658
29. Koehler D.R., Frndova H., Leung K., Louca E., Palmer D., Ng P., McKerlie C., Cox P., Coates A.L., and Hu J. Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter. J. Gene Med. 7 (2005) 1409-1420
30. Koehler D.R., Martin B., Corey M., Palmer D., Ng P., Tanswell A.K., and Hu J. Readministration of helper-dependent adenovirus to mouse lung. Gene Ther. 13 (2006) 773-780
31. Tosi M.F., van H.A., Ferkol T.W., Askew D., Harding C.V., and Kaplan J.M. Effect of Pseudomonas-induced chronic lung inflammation on specific cytotoxic T-cell responses to adenoviral vectors in mice. Gene Ther. 11 (2004) 1427-1433
32. Koehler D.R., Sajjan U., Chow Y.H., Martin B., Kent G., Tanswell A.K., McKerlie C., Forstner J.F., and Hu J. Protection of CFTR knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing CFTR in airway epithelia. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15364-15369
33. van Heeckeren A.M., Schluchter M.D., Xue W., and Davis P.B. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice. Am. J. Respir. Crit. Care Med. 173 (2006) 288-296
34. Moss R.B., Rodman D., Spencer L.T., Aitken M.L., Zeitlin P.L., Waltz D., Milla C., Brody A.S., Clancy J.P., Ramsey B., Hamblett N., and Heald A.E. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest 125 (2004) 509-521
35. Moss R.B., Milla C., Colombo J., Accurso F., Zeitlin P.L., Clancy J.P., Spencer L.T., Pilewski J., Waltz D.A., Dorkin H.L., Ferkol T., Pian M., Ramsey B., Carter B.J., Martin D.B., and Heald A.E. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. Hum. Gene Ther. 18 (2007) 726-732
36. Sirninger J., Muller C., Braag S., Tang Q., Yue H., Detrisac C., Ferkol T., Guggino W.B., and Flotte T.R. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector. Hum. Gene Ther. 15 (2004) 832-841
37. Virella-Lowell I., Zusman B., Foust K., Loiler S., Conlon T., Song S., Chesnut K.A., Ferkol T., and Flotte T.R. Enhancing rAAV vector expression in the lung. J. Gene Med. 7 (2005) 842-850
38. Gao G., Vandenberghe L.H., and Wilson J.M. New recombinant serotypes of AAV vectors. Curr. Gene Ther. 5 (2005) 285-297
39. Xie Q., Bu W., Bhatia S., Hare J., Somasundaram T., Azzi A., and Chapman M.S. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10405-10410
40. Shi W., and Bartlett J.S. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism. Mol. Ther. 7 (2003) 515-525
41. Duan D., Yue Y., and Engelhardt J.F. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol. Ther. 4 (2001) 383-391
42. Halbert C.L., Allen J.M., and Miller A.D. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat. Biotechnol. 20 (2002) 697-701
43. Ostedgaard L.S., Rokhlina T., Karp P.H., Lashmit P., Afione S., Schmidt M., Zabner J., Stinski M.F., Chiorini J.A., and Welsh M.J. A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2952-2957
44. Fischer A.C., Smith C.I., Cebotaru L., Zhang X., Askin F.B., Wright J., Guggino S.E., Adams R.J., Flotte T., and Guggino W.B. Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates. Mol. Ther. 15 (2007) 756-763
45. Mueller C., Torrez D., Braag S., Martino A., Clarke T., Campbell-Thompson M., and Flotte T.R. Partial correction of the CFTR-dependent ABPA mouse model with recombinant adeno-associated virus gene transfer of truncated CFTR gene. J. Gene Med. 10 (2007) 51-60
46. Halbert C.L., Lam S.L., and Miller A.D. High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung. Hum. Gene Ther. 18 (2007) 344-354
47. Beck S.E., Jones L.A., Chesnut K., Walsh S.M., Reynolds T.C., Carter B.J., Askin F.B., Flotte T.R., and Guggino W.B. Repeated delivery of adeno-associated virus vectors to the rabbit airway. J. Virol. 73 (1999) 9446-9455
48. Halbert C.L., Standaert T.A., Aitken M.L., Alexander I.E., Russell D.W., and Miller A.D. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J. Virol. 71 (1997) 5932-5941
49. Halbert C.L., Rutledge E.A., Allen J.M., Russell D.W., and Miller A.D. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74 (2000) 1524-1532
50. Auricchio A., O'Connor E., Weiner D., Gao G.P., Hildinger M., Wang L., Calcedo R., and Wilson J.M. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J. Clin. Invest. 110 (2002) 499-504
51. Fischer A.C., Beck S.E., Smith C.I., Laube B.L., Askin F.B., Guggino S.E., Adams R.J., Flotte T.R., and Guggino W.B. Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques. Mol. Ther. 8 (2003) 918-926
52. Halbert C.L., Liggit D., and Miller A.D. Biosafety study of an adeno-associated virus 6 vector in rats. Ped. Pulm. S28 (2005) 277-278
53. Yan Z., Zak R., Zhang Y., Ding W., Godwin S., Munson K., Peluso R., and Engelhardt J.F. Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia. J. Virol. 78 (2004) 2863-2874
54. Liu X., Luo M., Guo C., Yan Z., Wang Y., and Engelhardt J.F. Comparative biology of rAAV transduction in ferret, pig and human airway epithelia. Gene Ther. 14 (2007) 1543-1548
55. Ferrari S., Griesenbach U., Shiraki-Iida T., Shu T., Hironaka T., Hou X., Williams J., Zhu J., Jeffery P.K., Geddes D.M., Hasegawa M., and Alton E.W. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther. 11 (2004) 1659-1664
56. Zhang L., Bukreyev A., Thompson C.I., Watson B., Peeples M.E., Collins P.L., and Pickles R.J. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J. Virol. 79 (2005) 1113-1124
57. Ferrari S., Griesenbach U., Iida A., Farley R., Wright A.M., Zhu J., Munkonge F.M., Smith S.N., You J., Ban H., Inoue M., Chan M., Singh C., Verdon B., Argent B.E., Wainwright B., Jeffery P.K., Geddes D.M., Porteous D.J., Hyde S.C., Gray M.A., Hasegawa M., and Alton E.W. Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther. 14 (2007) 1371-1379
58. Inoue M., Tokusumi Y., Ban H., Kanaya T., Tokusumi T., Nagai Y., Iida A., and Hasegawa M. Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J. Virol. 77 (2003) 3238-3246
59. Griesenbach U., Geddes D.M., and Alton E.W. Gene therapy progress and prospects: cystic fibrosis. Gene Ther. 13 (2006) 1061-1067
60. Wang G., Williams G., Xia H., Hickey M., Shao J., Davidson B.L., and McCray P.B. Apical barriers to airway epithelial cell gene transfer with amphotropic retroviral vectors. Gene Ther. 9 (2002) 922-931
61. Limberis M., Anson D.S., Fuller M., and Parsons D.W. Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum. Gene Ther. 13 (2002) 1961-1970
62. Sinn P.L., Hickey M.A., Staber P.D., Dylla D.E., Jeffers S.A., Davidson B.L., Sanders D.A., and McCray Jr. P.B. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J. Virol. 77 (2003) 5902-5910
63. Kobayashi M., Iida A., Ueda Y., and Hasegawa M. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J. Virol. 77 (2003) 2607-2614
64. Mitomo K., Griesenbach U., Inoue M., Washizawa K., Fuijiawa S., Iwasaki H., Somerton L., Farley R., Singh C., Hasegawa M., and Alton E.W. Potential airway stem/progenitor cell integration after transduction with a lentiviral vector pseudotyped with sendai virus envelope proteins. Ped. Pulm. S30 (2007)
65. Sinn P.L., Burnight E.R., Hickey M.A., Blissard G.W., and McCray Jr. P.B. Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J. Virol. 79 (2005) 12818-12827
66. Kobinger G.P., Limberis M.P., Somanathan S., Schumer G., Bell P., and Wilson J.M. Human immunodeficiency viral vector pseudotyped with the spike envelope of severe acute respiratory syndrome coronavirus transduces human airway epithelial cells and dendritic cells. Hum. Gene Ther. 18 (2007) 413-422
67. Sinn P.L., Arias A.C., and McCray P.B. Repeated administration if lentiviral vector to mouse nasal epithelia enhances expression without emergence of blocking mucosal immune responses. Mol. Ther. 15 (2007)
68. Hyde S.C., Southern K.W., Gileadi U., Fitzjohn E.M., Mofford K.A., Waddell B.E., Gooi H.C., Goddard C.A., Hannavy K., Smyth S.E., Egan J.J., Sorgi F.L., Huang L., Cuthbert A.W., Evans M.J., Colledge W.H., Higgins C.F., Webb A.K., and Gill D.R. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 7 (2000) 1156-1165
69. Desigaux L., Gourden C., Bello-Roufai M., Richard P., Oudrhiri N., Lehn P., Escande D., Pollard H., and Pitard B. Nonionic amphiphilic block copolymers promote gene transfer to the lung. Hum. Gene Ther. 16 (2005) 821-829
70. Kichler A., Leborgne C., Marz J., Danos O., and Bechinger B. Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1564-1568
71. Meng Q.H., Robinson D., Jenkins R.G., McAnulty R.J., and Hart S.L. Efficient transfection of non-proliferating human airway epithelial cells with a synthetic vector system. J. Gene Med. 6 (2004) 210-221
72. Montier T., Delepine P., Marianowski R., Le N.K., Le B.M., Gillet D., Potard G., Mondine P., Frachon I., Yaouanc J.J., Clement J.C., Des A.H., and Ferec C. CFTR transgene expression in primary DeltaF508 epithelial cell cultures from human nasal polyps following gene transfer with cationic phosphonolipids. Mol. Biotechnol. 26 (2004) 193-206
73. Stern M., Ulrich K., Geddes D.M., and Alton E.W. Poly (d, l-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Ther. 10 (2003) 1282-1288
74. Griesenbach U., Wasowicz M.Y., Smith S.N., Wodehouse T., Fox E., Somerton L., et al. Endpoint assay development and validation of non-viral gene transfer agents in CF mice. Ped. Pulm. S28 (2005)
75. Gazdhar A., Fachinger P., van L.C., Pierog J., Gugger M., Friis R., Schmid R.A., and Geiser T. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007) L529-L536
76. Mutlu G.M., hado-Aranda D., Norton J.E., Bellmeyer A., Urich D., Zhou R., and Dean D.A. Electroporation-mediated gene transfer of the Na+,K+-ATPase rescues endotoxin-induced lung injury. Am. J. Respir. Crit Care Med. 176 (2007) 582-590
77. Pringle I.A., McLachlan G., Collie D.D., Sumner-Jones S.G., Lawton A.E., Tennant P., Baker A., Gordon C., Blundell R., Varathalingam A., Davies L.A., Schmid R.A., Cheng S.H., Porteous D.J., Gill D.R., and Hyde S.C. Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung. J. Gene Med. 9 (2007) 369-380
78. Xenariou S., Griesenbach U., Ferrari S., Dean P., Scheule R.K., Cheng S.H., Geddes D.M., Plank C., and Alton E.W. Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther. 13 (2006) 1545-1552
79. Xenariou S., Griesenbach U., Liang H.D., Zhu J., Farley R., Somerton L., Singh C., Jeffery P.K., Ferrari S., Scheule R.K., Cheng S.H., Geddes D.M., Blomley M., and Alton E.W. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther. 14 (2007) 768-774
80. Alton E.W., Stern M., Farley R., Jaffe A., Chadwick S.L., Phillips J., Davies J., Smith S.N., Browning J., Davies M.G., Hodson M.E., Durham S.R., Li D., Jeffery P.K., Scallan M., Balfour R., Eastman S.J., Cheng S.H., Smith A.E., Meeker D., and Geddes D.M. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 353 (1999) 947-954
81. Ruiz F.E., Clancy J.P., Perricone M.A., Bebok Z., Hong J.S., Cheng S.H., Meeker D.P., Young K.R., Schoumacher R.A., Weatherly M.R., Wing L., Morris J.E., Sindel L., Rosenberg M., van Ginkel F.W., McGhee J.R., Kelly D., Lyrene R.K., and Sorscher E.J. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum. Gene Ther. 12 (2001) 751-761
82. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
83. Yew N.S., Zhao H., Wu I.H., Song A., Tousignant J.D., Przybylska M., and Cheng S.H. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. 1 (2000) 255-262
84. Gill D.R., Smyth S.E., Goddard C.A., Pringle I.A., Higgins C.F., Colledge W.H., and Hyde S.C. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther. 8 (2001) 1539-1546
85. Yew N.S., Przybylska M., Ziegler R.J., Liu D., and Cheng S.H. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol. Ther. 4 (2001) 75-82
86. Koehler D.R., Hannam V., Belcastro R., Steer B., Wen Y., Post M., Downey G., Tanswell A.K., and Hu J. Targeting transgene expression for cystic fibrosis gene therapy. Mol. Ther. 4 (2001) 58-65
87. Ostrowski L.E., Hutchins J.R., Zakel K., and O'Neal W.K. Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter. Mol. Ther. 8 (2003) 637-645
88. Aneja M.K., Imker R., and Rudolph C. Phage phiC31 integrase-mediated genomic integration and long-term gene expression in the lung after nonviral gene delivery. J. Gene Med. 9 (2007) 967-975
89. Gruenert D.C., Kunzelmann K., Novelli G., Colosimo A., Kapsa R., and Bruscia E. Oligonucleotide-based gene targeting approaches. Oligonucleotides 14 (2004) 157-158
90. Liu X., Luo M., Zhang L.N., Yan Z., Zak R., Ding W., Mansfield S.G., Mitchell L.G., and Engelhardt J.F. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells. Hum. Gene Ther. 16 (2005) 1116-1123
91. Sangiuolo F., Scaldaferri M.L., Filareto A., Spitalieri P., Guerra L., Favia M., Caroppo R., Mango R., Bruscia E., Gruenert D.C., Casavola V., De F.M., and Novelli G. CFTR gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR). Front. Biosci. 13 (2008) 2989-2999
92. Barnes P.J. Nuclear factor-kappa B. Int. J. Biochem. Cell Biol. 29 (1997) 867-870
93. Lambert G., Becker B., Schreiber R., Boucherot A., Reth M., and Kunzelmann K. Control of cystic fibrosis transmembrane conductance regulator expression by BAP31. J. Biol. Chem. 276 (2001) 20340-20345
94. Mall M., Grubb B.R., Harkema J.R., O'Neal W.K., and Boucher R.C. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat. Med. 10 (2004) 487-493
95. Sheridan M.B., Fong P., Groman J.D., Conrad C., Flume P., Diaz R., Harris C., Knowles M., and Cutting G.R. Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. Hum. Mol. Genet. 14 (2005) 3493-3498
96. Kotton D.N., Ma B.Y., Cardoso W.V., Sanderson E.A., Summer R.S., Williams M.C., and Fine A. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128 (2001) 5181-5188
97. Krause D.S., Theise N.D., Collector M.I., Henegariu O., Hwang S., Gardner R., Neutzel S., and Sharkis S.J. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 (2001) 369-377
98. Kotton D.N., Fabian A.J., and Mulligan R.C. Failure of bone marrow to reconstitute lung epithelium. Am. J. Respir. Cell Mol. Biol. 33 (2005) 328-334
99. Macpherson H., Keir P., Webb S., Samuel K., Boyle S., Bickmore W., Forrester L., and Dorin J. Bone marrow-derived SP cells can contribute to the respiratory tract of mice in vivo. J. Cell Sci. 118 (2005) 2441-2450
100. Bishop A.E. Pulmonary epithelial stem cells. Cell Prolif. 37 (2004) 89-96
101. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., and Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121 (2005) 823-835
102. Dorin J.R. Animal Models. In: Bush A., Alton E.W., Davies J.C., Griesenbach U., and Jaffe A. (Eds). Progress in Respiratory Research: Cystic Fibrosis in the 21st Century (2006), Karger 84-92
103. Ostrowski L.E., Yin W., Diggs P.S., Rogers T.D., O'Neal W.K., and Grubb B.R. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice. Gene Ther. 14 (2007) 1492-1501
104. Ostrowski L.E., Yin W., Diggs P.S., Rogers T.D., O'Neal W.K., and Grubb B.R. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice. Gene Ther. 14 (2007) 1492-1501
105. Boucher R.C. Evidence for airway surface dehydration as the initiating event in CF airway disease. J. Intern. Med. 261 (2007) 5-16
106. Cunningham S., Meng Q.H., Klein N., McAnulty R.J., and Hart S.L. Evaluation of a porcine model for pulmonary gene transfer using a novel synthetic vector. J. Gene Med. 4 (2002) 438-446
107. McLachlan G., Baker A., Tennant P., Gordon C., Vrettou C., Renwick L., Blundell R., Cheng S.H., Scheule R.K., Davies L., Painter H., Coles R.L., Lawton A.E., Marriott C., Gill D.R., Hyde S.C., Griesenbach U., Alton E.W., Boyd A.C., Porteous D.J., and Collie D.D. Optimizing aerosol gene delivery and expression in the ovine lung. Mol. Ther. 15 (2007) 348-354
108. McDonald R.J., Lukason M.J., Raabe O.G., Canfield D.R., Burr E.A., Kaplan J.M., Wadsworth S.C., and St George J.A. Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primate. Hum. Gene Ther. 8 (1997) 411-422
109. Li Z., Sun X., Chen J., Liu X., Wisely S.M., Zhou Q., Renard J.P., Leno G.H., and Engelhardt J.F. Cloned ferrets produced by somatic cell nuclear transfer. Dev. Biol. 293 (2006) 439-448
110. Davies J.C., and Alton E.W.F.W. Clinical outcome measures to assess new treatments for CF lung disease. In: Hodson M., Geddes D.M., and Bush A. (Eds). Cystic Fibrosis vol. 3 (2007), Hodder Arnold, London 375-384
111. Konstan M.W., Davis P.B., Wagener J.S., Hilliard K.A., Stern R.C., Milgram L.J., Kowalczyk T.H., Hyatt S.L., Fink T.L., Gedeon C.R., Oette S.M., Payne J.M., Muhammad O., Ziady A.G., Moen R.C., and Cooper M.J. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum. Gene Ther. 15 (2004) 1255-1269
112. Zabner J., Couture L.A., Gregory R.J., Graham S.M., Smith A.E., and Welsh M.J. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75 (1993) 207-216
113. Crystal R.G., McElvaney N.G., Rosenfeld M.A., Chu C.S., Mastrangeli A., Hay J.G., Brody S.L., Jaffe H.A., Eissa N.T., and Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8 (1994) 42-51
114. Knowles M.R., Hohneker K.W., Zhou Z., Olsen J.C., Noah T.L., Hu P.C., Leigh M.W., Engelhardt J.F., Edwards L.J., and Jones K.R. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333 (1995) 823-831
115. Hay J.G., McElvaney N.G., Herena J., and Crystal R.G. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum. Gene Ther. 6 (1995) 1487-1496
116. Zabner J., Ramsey B.W., Meeker D.P., Aitken M.L., Balfour R.P., Gibson R.L., Launspach J., Moscicki R.A., Richards S.M., and Standaert T.A. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Invest. 97 (1996) 1504-1511
117. Bellon G., Michel-Calemard L., Thouvenot D., Jagneaux V., Poitevin F., Malcus C., Accart N., Layani M.P., Aymard M., Bernon H., Bienvenu J., Courtney M., Doring G., Gilly B., Gilly R., Lamy D., Levrey H., Morel Y., Paulin C., Perraud F., Rodillon L., Sene C., So S., Touraine-Moulin F., and Pavirani A. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Hum. Gene Ther. 8 (1997) 15-25
118. Zuckerman J.B., Robinson C.B., McCoy K.S., Shell R., Sferra T.J., Chirmule N., Magosin S.A., Propert K.J., Brown-Parr E.C., Hughes J.V., Tazelaar J., Baker C., Goldman M.J., and Wilson J.M. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum. Gene Ther. 10 (1999) 2973-2985
119. Perricone M.A., Morris J.E., Pavelka K., Plog M.S., O'Sullivan B.P., Joseph P.M., Dorkin H., Lapey A., Balfour R., Meeker D.P., Smith A.E., Wadsworth S.C., and St G.J. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium. Hum. Gene Ther. 12 (2001) 1383-1394
120. Wagner J.A., Messner A.H., Moran M.L., Daifuku R., Kouyama K., Desch J.K., Manley S., Norbash A.M., Conrad C.K., Friborg S., Reynolds T., Guggino W.B., Moss R.B., Carter B.J., Wine J.J., Flotte T.R., and Gardner P. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Laryngoscope 109 (1999) 266-274
121. Aitken M.L., Moss R.B., Waltz D.A., Dovey M.E., Tonelli M.R., McNamara S.C., Gibson R.L., Ramsey B.W., Carter B.J., and Reynolds T.C. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum. Gene Ther. 12 (2001) 1907-1916
122. Wagner J.A., Nepomuceno I.B., Messner A.H., Moran M.L., Batson E.P., Dimiceli S., Brown B.W., Desch J.K., Norbash A.M., Conrad C.K., Guggino W.B., Flotte T.R., Wine J.J., Carter B.J., Reynolds T.C., Moss R.B., and Gardner P. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum. Gene Ther. 13 (2002) 1349-1359
123. Flotte T.R., Zeitlin P.L., Reynolds T.C., Heald A.E., Pedersen P., Beck S., Conrad C.K., Brass-Ernst L., Humphries M., Sullivan K., Wetzel R., Taylor G., Carter B.J., and Guggino W.B. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum. Gene Ther. 14 (2003) 1079-1088
124. Caplen N.J., Alton E.W., Middleton P.G., Dorin J.R., Stevenson B.J., Gao X., Durham S.R., Jeffery P.K., Hodson M.E., and Coutelle C. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med. 1 (1995) 39-46
125. Gill D.R., Southern K.W., Mofford K.A., Seddon T., Huang L., Sorgi F., Thomson A., MacVinish L.J., Ratcliff R., Bilton D., Lane D.J., Littlewood J.M., Webb A.K., Middleton P.G., Colledge W.H., Cuthbert A.W., Evans M.J., Higgins C.F., and Hyde S.C. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4 (1997) 199-209
126. Porteous D.J., Dorin J.R., McLachlan G., vidson-Smith H., Davidson H., Stevenson B.J., Carothers A.D., Wallace W.A., Moralee S., Hoenes C., Kallmeyer G., Michaelis U., Naujoks K., Ho L.P., Samways J.M., Imrie M., Greening A.P., and Innes J.A. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4 (1997) 210-218
127. Noone P.G., Hohneker K.W., Zhou Z., Johnson L.G., Foy C., Gipson C., Jones K., Noah T.L., Leigh M.W., Schwartzbach C., Efthimiou J., Pearlman R., Boucher R.C., and Knowles M.R. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol. Ther. 1 (2000) 105-114
128. Zabner J., Cheng S.H., Meeker D., Launspach J., Balfour R., Perricone M.A., Morris J.E., Marshall J., Fasbender A., Smith A.E., and Welsh M.J. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J. Clin. Invest. 100 (1997) 1529-1537
129. Hyde S.C., Pringle I.A., Abdullah S., Lawton A.E., Davies L.A., Varathalingam A., Nunez-Alonso G., Green A.M., Bazzani R.P., Sumner-Jones S.G., Chan M., Li H., Yew N.S., Cheng S.H., Christopher B.A., Davies J.C., Griesenbach U., Porteous D.J., Sheppard D.N., Munkonge F.M., Alton E.W., and Gill D.R. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol. 26 (2008) 549-551
130. Griesenbach U., Kitson C., Escudero G.S., Farley R., Singh C., Somerton L., Painter H., Smith R.L., Gill D.R., Hyde S.C., Chow Y.H., Hu J., Gray M., Edbrooke M., Ogilvie V., MacGregor G., Scheule R.K., Cheng S.H., Caplen N.J., and Alton E.W. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respir. Res. 7 (2006) 26-41
131. Rogers C.S., Hao Y., Rokhlina T., Samuel M., Stoltz D.A., Li Y., Petroff E., Vermeer D.W., Kabel A.C., Yan Z., Spate L., Wax D., Murphy C.N., Rieke A., Whitworth K., Linville M.L., Korte S.W., Engelhardt J.E., Welsh M.J., and Prather R.S. Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J. Clin. Invest. 118 (2008) 1571-1577
132. Rogers C.S., Stoltz D.A., Meyerholz D.K., Ostedgaard L.S., Rokhlina T., Taft P.J., Rogan M.P., Pezzulo A.A., Karp P.H., Itani O.A., Kabel A.C., Wohlford-Lenane C.L., Davis G.J., Hanfland A., Smith T.L., Samuel M., Wax D., Murphy C.N., Rieke A., Whitworth K., Uc A., Starner T.D., Brogden K.A., Shilyansky J., McCray P.B., Zabner Jr. J., Prather R.S., and Welsh M.J. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321 (2008) 1837-1841